Breast Implants Market Report 2025

This Breast Implants market report covers market characteristics, size & growth, segmentation, regional & country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The breast implants market size has grown strongly in recent years. It will grow from $2.62 billion in 2024 to $2.83 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to growth in beauty and cosmetic surgery, increased breast cancer awareness, increased demand for minimally invasive breast augmentation, evolved aesthetic preferences and body image perception, and growth in medical tourism and globalization of plastic surgery.

The breast implants market size is expected to see strong growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing emphasis on personalized breast augmentation solutions, expanding applications in transgender and gender confirmation surgery, market expansion in emerging economies, growing acceptance of cosmetic procedures in society, and emphasis on natural-looking results and reduced complications. Major trends in the forecast period include sustainability and eco-friendly implants, patient-centric healthcare, telemedicine and virtual consultations, fat transfer procedures, and combination procedures.

The breast implants market is experiencing growth due to several factors, with a significant contribution from the rising incidence of breast cancer. Breast cancer surgery is a crucial aspect of breast cancer treatment, often involving the removal of breast tissue or lymph nodes. After such surgeries, breast implants are used by patients to restore the breast's shape and size, aiding in the recovery of a natural body appearance. The American Cancer Society reported around 297,790 new cases of invasive breast cancer in women in 2023, underscoring the increasing prevalence of this condition. This trend is anticipated to drive the growth of the breast implants market as more individuals opt for breast reconstruction procedures.

Government initiatives focused on research and development in healthcare are expected to further propel the breast implants market. Governments are increasingly investing in healthcare initiatives to support various aspects of medical research, including breast implants. For example, the UK government committed £260 million (approximately US $270.65 million) in funding to boost healthcare research and manufacturing in 2022. This funding aims to support NHS-led health research, develop diagnostics and treatments, and expand life sciences manufacturing in the UK. Such initiatives create a conducive environment for advancements in breast implant technologies.

Leading companies in the breast implants market are concentrating on technological innovations such as cohesive silicone gel to improve patient safety, enhance aesthetic results, and boost the durability and lifespan of implants, ultimately aiming to satisfy the changing needs of consumers and healthcare professionals. Cohesive silicone gel is a type of silicone utilized in breast implants that preserves its shape and integrity while offering a natural feel, minimizing the risk of leakage if the implant sustains damage. For example, GC Aesthetics, a privately owned medical technology firm, introduced the LUNA XTTM anatomical breast implant, which features a micro-textured surface designed to improve tissue integration and decrease complications.

The breast implants market is witnessing innovative developments from major companies, contributing to its growth. For example, Sientra, a US-based breast implant manufacturer, launched high-strength cohesive silicone gel breast implants in Canada in July 2023. This introduction represents a significant milestone for Sientra and underscores the company's commitment to delivering innovative and high-quality medical devices for plastic and reconstructive surgery. The new breast implants aim to provide a more natural look and feel, featuring clinically proven low complication rates. Sientra's entry into the Canadian market with these implants reflects its dedication to expanding its global presence and meeting the diverse needs of patients and healthcare professionals.

In December 2022, Integra LifeSciences, a US-based science company, acquired Surgical Innovation Associates (SIA) for $50 million. This acquisition is anticipated to enhance Integra's global strategy in breast reconstruction and broaden its efforts to enter the US market with FDA-approved devices for implant-based breast reconstruction (IBBR) procedures. Surgical Innovation Associates (SIA) is a US-based company that specializes in developing breast implants.

Major companies operating in the breast implants market include Sientra Inc., GC Aesthetics plc, HansBiomed Corp., Establishment Labs Holdings Inc., Silimed Indústria de Implantes Ltda., Ideal Implant Incorporated, Polytech Health & Aesthetics GmbH, Sebbin SAS, Establishment Labs S.A., Surgiform Technology Ltd., Johnson & Johnson, Guangzhou Wanhe Plastic Materials Co. Ltd., Hans Biomed Co. Ltd., G&G Biotechnology Ltd., Groupe SEBBIN SAS, Mentor Worldwide LLC, Arion Laboratories LLC, Hans Biomed Corp., Actavis plc, Nagor Limited, Lattice Medical, Motiva Implants, RTI Surgical Holdings Inc., Shanghai Kangning Medical Supplies Ltd., Thinkers Enterprise Co. Ltd., Adoderm GmbH, WestPac Surgical LLC, AirXpanders Inc., Koken Co. Ltd., Groupe Brochard.

Breast implants, designed as breast-shaped pouches with a silicone outer shell and filled with either silicone gel or saline, are utilized to alter the size, shape, and appearance of the breasts.

Key categories of breast implants include silicone implants, form-stable implants, saline implants, and structured saline implants. Silicone implants, filled with silicone gel that closely mimics natural breast tissue, are employed in breast augmentation and breast reconstruction procedures. These products are utilized by various end-users, including hospitals, cosmetology clinics, and other establishments involved in cosmetic and reconstructive surgery.

The breast implants market research report is one of a series of new reports that provides breast implants market statistics, including breast implants industry global market size, regional shares, competitors with a breast implants market share, detailed breast implants market segments, market trends and opportunities, and any further data you may need to thrive in the breast implants industry. This breast implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the breast implants market in 2024. The regions covered in the breast implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the breast implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The breast implants market consists of sales of Saline-Filled Breast Implants, Silicone-Filled Breast Implants, and Breast Tissue Expanders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.